Celiac.com 11/05/2015 - Professional reports on various aspects celiac disease and gluten-free issues can be helpful for numerous people seeking to better understand what the current and future landscape will look like.
The latest such report is the EpiCast Report: Celiac Disease – Epidemiology Forecast to 2023. The celiac disease EpiCast Report provides an overview of the risk factors, co-morbidities, and the global and historical trends for celiac disease in the six major markets (6MM) (US, France, Germany, Italy, Spain, and UK).
The number of diagnosed prevalent cases in the 6MM is expected to increase by 4.61% over the next decade to 1.11 million cases in 2023.
According to the literature, GlobalDatas forecast and analysis is based on a thorough literature review and from primary research results, followed by a careful review of selected secondary research studies and validation of study findings with primary research by GlobalData epidemiologists.
The report stands out primarily because GlobalData epidemiologists maintained a consistent case-finding definition and forecasting methodology for celiac disease throughout the 6MM, which allows for a meaningful comparison of the total and diagnosed prevalent cases of celiac disease in these markets.
The report further breaks down total prevalent cases of celiac disease by sex, thus providing a detailed analysis of the patient population characteristic of celiac disease. Additionally, GlobalData epidemiologists also provided a realistic trend forecast for the total and diagnosed prevalence of celiac disease based on insights gained through the analysis of historical data.
Lastly, the report also includes a comprehensive 10-year epidemiological celiac disease forecast broken down by sex and age (0-19 years, 20-29 years, 30-39 years, 40-49 years, 50-59 years, 60-69 years, and =70 years), and a 10-year epidemiological forecast for the diagnosed prevalent cases of celiac disease in the 6MM.